- Home
- SPRY vs DAVE Comparison
SPRY vs DAVE Comparison
Compare SPRY & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- DAVE
- Stock Information
- Founded
- SPRY 2015
- DAVE 2017
- Country
- SPRY United States
- DAVE United States
- Employees
- SPRY N/A
- DAVE N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- DAVE Retail: Computer Software & Peripheral Equipment
- Sector
- SPRY Health Care
- DAVE Technology
- Exchange
- SPRY Nasdaq
- DAVE Nasdaq
- Market Cap
- SPRY 1.1B
- DAVE 3.2B
- IPO Year
- SPRY N/A
- DAVE N/A
- Fundamental
- Price
- SPRY $9.18
- DAVE $251.02
- Analyst Decision
- SPRY Strong Buy
- DAVE Strong Buy
- Analyst Count
- SPRY 4
- DAVE 6
- Target Price
- SPRY $31.25
- DAVE $265.50
- AVG Volume (30 Days)
- SPRY 2.4M
- DAVE 388.4K
- Earning Date
- SPRY 11-12-2025
- DAVE 11-04-2025
- Dividend Yield
- SPRY N/A
- DAVE N/A
- EPS Growth
- SPRY N/A
- DAVE 70.95
- EPS
- SPRY N/A
- DAVE 3.84
- Revenue
- SPRY $112,339,000.00
- DAVE $433,065,000.00
- Revenue This Year
- SPRY N/A
- DAVE $50.28
- Revenue Next Year
- SPRY $193.13
- DAVE $15.34
- P/E Ratio
- SPRY N/A
- DAVE $64.70
- Revenue Growth
- SPRY 22367.80
- DAVE 47.97
- 52 Week Low
- SPRY $9.08
- DAVE $37.44
- 52 Week High
- SPRY $18.90
- DAVE $286.45
- Technical
- Relative Strength Index (RSI)
- SPRY 32.24
- DAVE 65.95
- Support Level
- SPRY $9.75
- DAVE $208.60
- Resistance Level
- SPRY $10.38
- DAVE $224.68
- Average True Range (ATR)
- SPRY 0.54
- DAVE 15.01
- MACD
- SPRY -0.07
- DAVE 4.28
- Stochastic Oscillator
- SPRY 0.00
- DAVE 92.59
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.